Inamed CEO (Chief Executive Officer) defends silicone for breast implants
This article was originally published in Clinica
Executive Summary
The co-CEO of Inamed, one of the two major US manufacturers of breast implants and the company which inherited the liability for the failed soya oil filled implants used in Europe, has explained why he believes that silicone gel should be re-introduced as a filler in the US market. He has defended the company's clinical trials with the product and its attempt to gain US FDA approval, despite silicone's history of leakage and possible health damage.